Is durvalumab the solution for unresectable stage III non-small cell lung cancer?
Year: 2018
Type: article
Abstract: Lung cancer is the leading cause of cancer deaths in the United States and worldwide (1). The majority of patients with newly diagnosed non-small cell lung cancers (NSCLC) have metastasis at presentation but a large group of patients present with locally or regionally advanced disease.
Source: Translational Cancer Research
Authors: Narjust Duma, Aaron S. Mansfield
Institution: Mayo Clinic
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2784856677